Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors

Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors

US Patent 8084481 · Granted Dec 27, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MASP inhibitory compounds and uses thereof2025
Substituted hydantoinamides as ADAMTS7 antagonists2025
Anti-semaphorin 3A antibodies2025
Substituted pyrazolo piperidine carboxylic acids2025
Anti-sema3a antibodies and uses thereof2024
Treatment of cardiopulmonary disorders2024
Substituted dihydroquinazolines2023
Substituted dihydroquinazolines2023
Combination containing sGC stimulators and mineralocorticoid receptor antagonist2023
MASP inhibitory compounds and uses thereof2023
Use of non-steroidal mineralocorticoid receptor antagonists alone or in combinat2022
Combination containing sGC activators and mineralocorticoid receptor antagonists2022